EMERYVILLE, Calif., Oct. 25, 2016 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2016 after market close on Wednesday, November 2, 2016.
The company will hold its quarterly conference call to discuss these results, as well as provide an update on the company's business and outlook, at 4:30 p.m. ET (1:30 p.m. PT) on Wednesday, November 2, 2016.
Conference Call:
Wednesday, November 2, 2016, 4:30 p.m. ET/1:30 p.m. PT
Dial-in Number:
(866) 516-3867 (U.S. & International)
Access Code: 5584794
Audio Webcast:
A live webcast of the call will be available online on the Amyris website. To listen via live webcast, please visit: http://investors.amyris.com. A replay of the webcast will be available on the Investor Relations section of the Company's website approximately two hours after the conclusion of the call.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are registered trademarks of Amyris, Inc.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Italy Fines Apple €98.6 Million Over App Store Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 



